Validation of the French version of the Global Functioning: Social and Global Functioning: Role Scales in adolescents and young adults seeking help in early intervention clinics.

at risk mental state functional predictors outcome prodromal schizophrenia youth mental health

Journal

Early intervention in psychiatry
ISSN: 1751-7893
Titre abrégé: Early Interv Psychiatry
Pays: Australia
ID NLM: 101320027

Informations de publication

Date de publication:
10 Apr 2023
Historique:
received: 13 12 2022
accepted: 28 03 2023
entrez: 10 4 2023
pubmed: 11 4 2023
medline: 11 4 2023
Statut: aheadofprint

Résumé

Social and role functioning impairments characterize patients along the schizophrenia spectrum, but the existing evaluations tools do not specifically address younger population issues. The Global Functioning Social (GF:S) and Global Functioning Role (GF:R) scales have been specifically designed for that purpose. The aim of this study is to establish the reliability and concurrent validity of the French version of GF:S and GF:R scales. The two scales GF: Social (GF:S) and Role (GF:R) have first been translated into French and independently back translated and validated by the original authors. Between March 2021 and March 2022, we enrolled 51 participants (20.3 ± 3.7 years old; female = 22/51) amongst help-seekers referring to two different early mental health services in the Île-de-France. In an ecological design, participants met different diagnoses, 7 (13.7%) met the criteria for Ultra-High Risk of psychosis (UHR) using CAARMS criteria. Inter-rater reliability was excellent for scores related to the past month and to the higher levels of functioning over the past year. Both scales showed good to excellent concurrent validity as measured by correlation with the Social and Occupational Functioning Assessment Scale (SOFAS) and the Personal and Social Performance Scale (PSP). Overall, this study confirms the reliability and validity of the French version of the GF:S and GF:R scales. The use of these scales may improve the evaluation of social and occupational functioning in French-speaking young help-seekers, in a transdiagnostic approach, both in clinical and research settings.

Identifiants

pubmed: 37037927
doi: 10.1111/eip.13427
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : RHU PsyCARE
ID : ANR-18-RHUS-0014
Organisme : French Ministry EDIPAJ Preps
Organisme : Fondation FondaMental-Fondation Bettencourt-Schueller

Informations de copyright

© 2023 John Wiley & Sons Australia, Ltd.

Références

Addington, J., Penn, D., Woods, S. W., Addington, D., & Perkins, D. O. (2008). Social functioning in individuals at clinical high risk for psychosis. Schizophrenia Research, 99(1-3), 119-124. https://doi.org/10.1016/j.schres.2007.10.001
Auther, A. M., Smith, C. W., & Cornblatt, B. A. (2006). Global functioning: Social scale (GF: Social). Zucker Hillside Hospital.
Blanc, O., Delgado, A., Lancon, C., Schwan, R., Schürhoff, F., Lesturgeon, J.-A., Thomas, P., & Llorca, P. M. (2010). P03-32-Validation of the French version of the personal and social performance scale (PSP). European Psychiatry, 25, 1153. https://doi.org/10.1016/S0924-9338(10)71142-1
Brissos, S., Molodynski, A., Dias, V. V., & Figueira, M. L. (2011). The importance of measuring psychosocial functioning in schizophrenia. Annals of General Psychiatry, 10(1), 18. https://doi.org/10.1186/1744-859X-10-18
Burton, C. Z., Tso, I. F., Carrión, R. E., Niendam, T., Adelsheim, S., Auther, A. M., Cornblatt, B. A., Carter, C. S., Melton, R., Sale, T. G., Taylor, S. F., & McFarlane, W. R. (2019). Baseline psychopathology and relationship to longitudinal functional outcome in attenuated and early first episode psychosis. Schizophrenia Research, 212, 157-162. https://doi.org/10.1016/j.schres.2019.07.048
Carrión, R. E., Auther, A. M., McLaughlin, D., Olsen, R., Addington, J., Bearden, C. E., Cadenhead, K. S., Cannon, T. D., Mathalon, D. H., McGlashan, T. H., Perkins, D. O., Seidman, L. J., Tsuang, M. T., Walker, E. F., Woods, S. W., & Cornblatt, B. A. (2019). The global functioning: Social and role scales-Further validation in a large sample of adolescents and young adults at clinical high risk for psychosis. Schizophrenia Bulletin, 45(4), 763-772. https://doi.org/10.1093/schbul/sby126
Carrión, R. E., McLaughlin, D., Goldberg, T. E., Auther, A. M., Olsen, R. H., Olvet, D. M., Correll, C. U., & Cornblatt, B. A. (2013). Prediction of functional outcome in individuals at clinical high risk for psychosis. JAMA Psychiatry, 70(11), 1133-1142. https://doi.org/10.1001/jamapsychiatry.2013.1909
Cornblatt, B. A., Auther, A. M., Niendam, T., Smith, C. W., Zinberg, J., Bearden, C. E., & Cannon, T. D. (2007). Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia. Schizophrenia Bulletin, 33(3), 688-702. https://doi.org/10.1093/schbul/sbm029
Engen, M. J., Vaskinn, A., Melle, I., Faerden, A., Lyngstad, S. H., Flaaten, C. B., Widing, L. H., Wold, K. F., Åsbø, G., Haatveit, B., Simonsen, C., & Ueland, T. (2022). Cognitive and global functioning in patients with first-episode psychosis stratified by level of negative symptoms. A 10-year follow-up study. Frontiers in Psychiatry, 13, 841057. https://doi.org/10.3389/fpsyt.2022.841057
Goldman, H. H., Skodol, A. E., & Lave, T. R. (1992). Revising axis V for DSM-IV: A review of measures of social functioning. The American journal of psychiatry, 149(9), 1148-1156. https://doi.org/10.1176/ajp.149.9.1148
Hall, R. C. W. (1995). Global assessment of functioning. Psychosomatics, 36(3), 267-275. https://doi.org/10.1016/S0033-3182(95)71666-8
Hamoda, H. M., Makhlouf, A. T., Fitzsimmons, J., Rathi, Y., Makris, N., Mesholam-Gately, R. I., Wojcik, J. D., Goldstein, J., McCarley, R. W., Seidman, L. J., Kubicki, M., & Shenton, M. E. (2019). Abnormalities in thalamo-cortical connections in patients with first-episode schizophrenia: A two-tensor tractography study. Brain Imaging and Behavior, 13(2), 472-481. https://doi.org/10.1007/s11682-018-9862-8
Krebs, M.-O., Magaud, E., Willard, D., Elkhazen, C., Chauchot, F., Gut, A., Morvan, Y., Bourdel, M.-C., & Kazes, M. (2014). Évaluation des états mentaux à risque de transition psychotique: Validation de la version française de la CAARMS. L'Encéphale, 40(6), 447-456. https://doi.org/10.1016/j.encep.2013.12.003
Lee, S. J., Kim, K. R., Lee, S. Y., & An, S. K. (2017). Impaired social and role function in ultra-high risk for psychosis and first-episode schizophrenia: Its relations with negative symptoms. Psychiatry Investigation, 14(5), 539-545. https://doi.org/10.4306/pi.2017.14.5.539
Lepock, J. R., Ahmed, S., Mizrahi, R., Gerritsen, C. J., Maheandiran, M., Bagby, R. M., Korostil, M., & Kiang, M. (2021). N400 event-related brain potential as an index of real-world and neurocognitive function in patients at clinical high risk for schizophrenia. Early Intervention in Psychiatry, 15(1), 68-75. https://doi.org/10.1111/eip.12911
Lim, K., Rapisarda, A., Keefe, R. S. E., & Lee, J. (2022). Social skills, negative symptoms and real-world functioning in individuals at ultra-high risk of psychosis. Asian Journal of Psychiatry, 69, 102996. https://doi.org/10.1016/j.ajp.2021.102996
Lo Cascio, N., Curto, M., Pasqualetti, P., Lindau, J. F., Girardi, N., Saba, R., Brandizzi, M., Monducci, E., Masillo, A., Colafrancesco, G., Solfanelli, A., De Crescenzo, F., Kotzalidis, G. D., Dario, C., Ferrara, M., Vicari, S., Girardi, P., Auther, A. M., Cornblatt, B. A., … Fiori Nastro, P. (2017). Impairment in social functioning differentiates youth meeting ultra-high risk for psychosis criteria from other mental health help-seekers: A validation of the Italian version of the global functioning: Social and global functioning: Role scales. Psychiatry Research, 253, 296-302. https://doi.org/10.1016/j.psychres.2017.04.008
Markulev, C., McGorry, P. D., Nelson, B., Yuen, H. P., Schaefer, M., Yung, A. R., Thompson, A., Berger, G., Mossaheb, N., Schlögelhofer, M., Smesny, S., de Haan, L., Riecher-Rössler, A., Nordentoft, M., Chen, E. Y. H., Verma, S., Hickie, I., & Amminger, G. P. (2017). NEURAPRO-E study protocol: A multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders: The NEURAPRO-E study protocol. Early Intervention in Psychiatry, 11(5), 418-428. https://doi.org/10.1111/eip.12260
McKown, S., Acquadro, C., Anfray, C., Arnold, B., Eremenco, S., Giroudet, C., Martin, M., & Weiss, D. (2020). Good practices for the translation, cultural adaptation, and linguistic validation of clinician-reported outcome, observer-reported outcome, and performance outcome measures. Journal of Patient-Reported Outcomes, 4(1), 89. https://doi.org/10.1186/s41687-020-00248-z
Morosini, P. L., Magliano, L., Brambilla, L., Ugolini, S., & Pioli, R. (2000). Development, reliability and acceptability of a new version of the DSM-IV social and occupational functioning assessment scale (SOFAS) to assess routine social funtioning. Acta Psychiatrica Scandinavica, 101(4), 323-329. https://doi.org/10.1034/j.1600-0447.2000.101004323.x
Niendam, T. A., Bearden, C. E., Johnson, J. K., & Cannon, T. D. (2006). Global functioning: Role scale (GF: Role). University of California, Los Angeles.
Piskulic, D., Addington, J., Auther, A., & Cornblatt, B. A. (2011). Using the global functioning social and role scales in a first-episode sample: Global functioning in psychosis. Early Intervention in Psychiatry, 5(3), 219-223. https://doi.org/10.1111/j.1751-7893.2011.00263.x
R Core Team. (2020). R: A language and environment for statistical computing. R Foundation for Statistical Computinghttps://www.R-project.org/
Romanowska, S., MacQueen, G., Goldstein, B. I., Wang, J., Kennedy, S. H., Bray, S., Lebel, C., & Addington, J. (2020). Social and role functioning in youth at risk of serious mental illness. Early Intervention in Psychiatry, 14(4), 463-469. https://doi.org/10.1111/eip.12872
Shah, J. L., Scott, J., McGorry, P. D., Cross, S. P. M., Keshavan, M. S., Nelson, B., Wood, S. J., Marwaha, S., Yung, A. R., Scott, E. M., Öngür, D., Conus, P., Henry, C., Hickie, I. B., & International Working Group on Transdiagnostic Clinical Staging in Youth Mental Health. (2020). Transdiagnostic clinical staging in youth mental health: A first international consensus statement. World Psychiatry, 19(2), 233-242. https://doi.org/10.1002/wps.20745
Ventura, J., Welikson, T., Ered, A., Subotnik, K. L., Keefe, R. S. E., Hellemann, G. S., & Nuechterlein, K. H. (2020). Virtual reality assessment of functional capacity in the early course of schizophrenia: Associations with cognitive performance and daily functioning. Early Intervention in Psychiatry, 14(1), 106-114. https://doi.org/10.1111/eip.12831
Yung, A. R., Yung, A. R., Pan Yuen, H., Mcgorry, P. D., Phillips, L. J., Kelly, D., Dell'olio, M., Francey, S. M., Cosgrave, E. M., Killackey, E., Stanford, C., Godfrey, K., & Buckby, J. (2005). Mapping the onset of psychosis: The comprehensive assessment of at-risk mental states. Australian & New Zealand Journal of Psychiatry, 39(11-12), 964-971. https://doi.org/10.1080/j.1440-1614.2005.01714.x

Auteurs

Valeria Lucarini (V)

Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Université Paris Cité, Paris, France.
CJAAD, Evaluation, Prevention and Therapeutic Innovation Department, GHU Paris Psychiatrie et Neurosciences, Paris, France.
Institut de Psychiatrie, CNRS GDR 3557, Paris, France.

Mathilde Kazes (M)

CJAAD, Evaluation, Prevention and Therapeutic Innovation Department, GHU Paris Psychiatrie et Neurosciences, Paris, France.
Institut de Psychiatrie, CNRS GDR 3557, Paris, France.

Emma Krebs (E)

Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Université Paris Cité, Paris, France.
Institut de Psychiatrie, CNRS GDR 3557, Paris, France.

Valentine Morin (V)

Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Université Paris Cité, Paris, France.
CJAAD, Evaluation, Prevention and Therapeutic Innovation Department, GHU Paris Psychiatrie et Neurosciences, Paris, France.
Institut de Psychiatrie, CNRS GDR 3557, Paris, France.

Maud Godignon (M)

CJAAD, Evaluation, Prevention and Therapeutic Innovation Department, GHU Paris Psychiatrie et Neurosciences, Paris, France.

Marie De Gasquet (M)

Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Université Paris Cité, Paris, France.
CJAAD, Evaluation, Prevention and Therapeutic Innovation Department, GHU Paris Psychiatrie et Neurosciences, Paris, France.
Institut de Psychiatrie, CNRS GDR 3557, Paris, France.

Trang Ton (T)

Institut de Psychiatrie, CNRS GDR 3557, Paris, France.
JENESIS/CRISALID, Pôle PRERPS, CHI EPSM Oise, Clermont de l'Oise, France.

Marion Féron (M)

Institut de Psychiatrie, CNRS GDR 3557, Paris, France.
JENESIS/CRISALID, Pôle PRERPS, CHI EPSM Oise, Clermont de l'Oise, France.

Guillaume Tanguy (G)

CJAAD, Evaluation, Prevention and Therapeutic Innovation Department, GHU Paris Psychiatrie et Neurosciences, Paris, France.

Agnès Lévi (A)

CJAAD, Evaluation, Prevention and Therapeutic Innovation Department, GHU Paris Psychiatrie et Neurosciences, Paris, France.

Cécile Bellot (C)

CJAAD, Evaluation, Prevention and Therapeutic Innovation Department, GHU Paris Psychiatrie et Neurosciences, Paris, France.

Dominique Willard (D)

Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Université Paris Cité, Paris, France.
CJAAD, Evaluation, Prevention and Therapeutic Innovation Department, GHU Paris Psychiatrie et Neurosciences, Paris, France.
Institut de Psychiatrie, CNRS GDR 3557, Paris, France.

Andrea M Auther (AM)

Division of Psychiatry Research, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, New York, New York, USA.
Department of Psychiatry, Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA.

Barbara Cornblatt (B)

Division of Psychiatry Research, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, New York, New York, USA.
Department of Psychiatry, Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA.
Center for Psychiatric Neuroscience, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA.
Department of Molecular Medicine, Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA.

Marie-Cécile Bralet (MC)

Institut de Psychiatrie, CNRS GDR 3557, Paris, France.
JENESIS/CRISALID, Pôle PRERPS, CHI EPSM Oise, Clermont de l'Oise, France.

Marie-Odile Krebs (MO)

Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Université Paris Cité, Paris, France.
CJAAD, Evaluation, Prevention and Therapeutic Innovation Department, GHU Paris Psychiatrie et Neurosciences, Paris, France.
Institut de Psychiatrie, CNRS GDR 3557, Paris, France.

Classifications MeSH